Introduction
The number of product information sites provided to consumers in the EU is limited, while disease and public education sites are abundant and are used to effectively target consumers, and sites targeting healthcare professionals in the EU are readily available. Sites must be optimized to of influence their target audiences, and to attract, convert and retain these important decision makers.
Scope
- Assess and compare the value of 18 leading pharmaceutical companies’ web presence across a number of criteria
- Identify which tools are needed to encourage European consumers and healthcare professionals to revisit a website and to drive new users to the site
- Identify how pharmaceutical companies provide information to European consumers without directly advertising their brand
Highlights
Reasons to Purchase
Other selected research from the 'Europe' category:
ICT Opportunities in European Financial Services: Investment drivers, targeting strategies and the leading players
The global economic downturn and equity market decline since the late 1990s badly affected the entire financial services industry and resulted in dramatic cuts in IT spending. Learn More
Drug Safety in the Post-Vioxx Era: New legislation, regulation and company strategies in Europe and the US
This report examines the actions taken by legislative and regulatory bodies in response to recent drug safety concerns surrounding the COX-2 inhibitors and antidepressants. Learn More
Other selected research from the 'IT & eHealth' category:
Effective Social Media Marketing Strategies for Pharmaceutical Market
The high and rapidly increasing popularity of social media platforms such as Facebook, YouTube, and Twitter is expected to revolutionize the marketing strategies employed in the pharmaceuticals industry. In addition... Learn More
Datamonitors eHealth Physician Insight Survey: 2005 Survey Results Overview
Work-related online access and use of online tools is gaining ground amongst physicians. While searching for health information online is an established practice among physicians, pharmaceutical companies must ensure the information they provide is accurate and user-friendly for physicians who have limited time. This PowerPoint insight survey pack identifies the growth potential for online tools. Learn More
Other selected research from the 'Pharmacoeconomics' category:
Pricing & Reimbursement Series:Medicare Part Ds progress so far
Overview of the complex Medicare Part D environment in the US, charting the program’s evolution over the last 15 months since roll-out, together with the problems that it has faced, and followed by identifying possible remedies to these issues. Learn More
Market Development in Anti-virals:What is Next?
This analysis deals with 26 of the most promising pharmaceutical companies with anti-viral drugs on the market. Indication by indication is measured by number of current therapies, present sales and sales development. Learn More